🚨 CONSUMER ALERT 🚨: The FDA reports that a substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac.
Patients who are taking prescription ranitidine and want to stop using it should discuss alternatives with their health care provider, the FDA advised. Those taking over-the-counter ranitidine could switch to other OTC medicines.NDMA is an environmental contaminant found in water and foods, including meats, dairy products and vegetables. It is classified as a probable human carcinogen.
The FDA said it's evaluating whether the low levels of NDMA in ranitidine pose a risk to patients and that it will post that information when it's available. In the meantime, Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said the FDA is working with international regulators and industry partners to find out where the contamination originated."The agency is examining levels of NDMA in ranitidine and evaluating any possible risk to patients," she said in a news release."The FDA will take appropriate measures based on the results of the ongoing investigation.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA finds impurity in popular heartburn medicine Zantac that could cause cancerThe FDA has learned that Sanofi's heartburn medication Zantac carries a substance that could cause cancer.
Consulte Mais informação »
U.S. and European regulators reviewing safety of heartburn drugs like ZantacU.S. and European drug regulators said on Friday they are reviewing the safety o...
Consulte Mais informação »
FDA finds low levels of cancer-linked impurity in common heartburn drugsThe US Food and Drug Administration said on Friday that it has learned that some heartburn medicines -- including Zantac -- contain low levels of a nitrosamine impurity known as N-nitrosodimethylamine or NDMA, which is a 'probable human carcinogen.'
Consulte Mais informação »
Juul says it will keep running 'Make the Switch' ad campaign despite FDA concernsThe FDA sent Juul a warning letter this week about its campaign urging people to 'Make the Switch' from cigarettes, but the company isn't backing down.
Consulte Mais informação »
Column: A stem cell clinic under fire by the FDA and ex-patients files for bankruptcyA La Jolla clinic pitching $15,000 stem cell treatments files for bankruptcy, facing a lawsuit from former patients.
Consulte Mais informação »